G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 1 100.6 INR -2.89% Market Closed
Market Cap: 134.9B INR

Wall Street
Price Targets

GLS Price Targets Summary
Glenmark Life Sciences Ltd

There are no price targets for GLS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Glenmark Life Sciences Ltd Competitors:
Price Targets
ALKEM
Alkem Laboratories Ltd
7% Upside
AUROPHARMA
Aurobindo Pharma Ltd
10% Upside
4887
Sawai Group Holdings Co Ltd
4% Upside
COHANCE
Cohance Lifesciences Ltd
54% Upside
AMPH
Amphastar Pharmaceuticals Inc
23% Upside
605507
Guobang Pharma Ltd
24% Upside

Revenue
Forecast

Revenue Estimate
Glenmark Life Sciences Ltd

For the last 4 years the compound annual growth rate for Glenmark Life Sciences Ltd's revenue is 10%. The projected CAGR for the next 3 years is 12%.

10%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Glenmark Life Sciences Ltd

For the last 4 years the compound annual growth rate for Glenmark Life Sciences Ltd's operating income is 9%. The projected CAGR for the next 3 years is 12%.

9%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Glenmark Life Sciences Ltd

For the last 4 years the compound annual growth rate for Glenmark Life Sciences Ltd's net income is 11%. The projected CAGR for the next 3 years is 15%.

11%
Past Growth
15%
Estimated Growth
Estimates Accuracy
0%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GLS's stock price target?
Not Available

GLS doesn't have any price targets made by Wall Street professionals.

What is Glenmark Life Sciences Ltd's Revenue forecast?
Projected CAGR
12%

For the last 4 years the compound annual growth rate for Glenmark Life Sciences Ltd's revenue is 10%. The projected CAGR for the next 3 years is 12%.

What is Glenmark Life Sciences Ltd's Operating Income forecast?
Projected CAGR
12%

For the last 4 years the compound annual growth rate for Glenmark Life Sciences Ltd's operating income is 9%. The projected CAGR for the next 3 years is 12%.

What is Glenmark Life Sciences Ltd's Net Income forecast?
Projected CAGR
15%

For the last 4 years the compound annual growth rate for Glenmark Life Sciences Ltd's net income is 11%. The projected CAGR for the next 3 years is 15%.

Back to Top